Dynavax Technologies Corp (NASDAQ:DVAX)

research

Top Biotech Stocks Under $5 With Huge Potential Upside

With the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could ...
Read Full Story »
dollar

Short Sellers Abandon Key Nasdaq Stocks — Short Covering Galore

Short selling has always been a difficult game. One of the reasons that many investors, both institutional and retail, avoid selling stock short is the potential for loss is unlimited. ...
Read Full Story »
biotech

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in ...
Read Full Story »
Bull and Bear figures

Closing Bell for Thursday on Wall Street: Markets Recoup from Low Open to Post Gain

U.S. equity markets opened lower this morning, but gathered steam following encouraging reports on new claims for jobless benefits (down) and retail sales (up). There was little economic data from ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less than expected, producer prices fell, fixed asset investment rose a ...
Read Full Story »
biotech

FDA Response Letter Takes over $100M from Dynavax Value

Dynavax Technologies Corp. (NASDAQ: DVAX) was a small cap stock even before today's news, but a complete response letter from U.S. Food and Drug Administration (FDA) has taken more than ...
Read Full Story »
Barnes and Noble

Today’s Market Winners and Losers

The stock market is mixed Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq up 0.17% and the S&P 500 down 0.01%. Today's winners are an online gaming firm ...
Read Full Story »

Death for Dynavax’s Lead Drug Candidate

Dynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was insufficient data to support its investigational Hepatitis B drug called ...
Read Full Story »

BioHealth Business Daily (AEZS, ANDS, ACHN, AKRX, DVAX, GENZ, IDIX, MIPI, RPRX, SNTS, WCRX)

Today's episode of the BioHealth Business Daily has many stocks moving on hepatitis news and starting with the letter "A" coincidentally.  Shares of AEterna Zentaris (NASDAQ: AEZS), Anadys Pharmaceuticals, Inc. ...
Read Full Story »

Top Day Trader Alerts (DVAX, ME, IDIX, MGM, WYNN, LVS, SNTS, UPS)

These are this some of this Thursday's top pre-market movers on news this morning.  A few links have been provided to show more detail and analysis over at VSInvestor.com: Dynavax ...
Read Full Story »

Top After-Hours Stock Movers (YUM, UPS, REVU, DVAX, MGM, SNTS)

Earnings are moving stocks, yet some are moving on other news as well in the after-hours trading session.  YUM! Brands Inc. (NYSE: YUM), United Parcel Service, Inc. (NYSE: UPS), Princeton ...
Read Full Story »

BioHealth Business Daily (ARAY, BEC, BPAX, CTIC, CHTP, DVAX, NABI, ONTY, SQNM, SOMX, WHRT)

Today's BioHealth Business Daily is full of some of the names you might expect to see, but it also has some unusual names as well.  We are seeing share price ...
Read Full Story »
biotech image

BioHealth Business Daily (BMRN, DVAX, SEPR, STEM, PCYC, OCLS)

Today is an unusually active day for many emerging biotech stocks in the news and we are seeing significant moves in response. We have more detail on each with appropriate ...
Read Full Story »
Down_arrow_red_2

Biotech Implosion: Dynavax (DVAX)

Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today.  The company gave an update on an FDA clinical hold on its investigational ...
Read Full Story »
Down_arrow_red

Top Pre-Market Analyst Downgrades (AMP, AAPL, DVAX, FCX, GMT, LNC, PCX, X)

These are some of the top pre-market analyst downgrades from Wall Street this Wednesday morning:Ameriprise Financial (AMP) Cut to Market Perform at KBW.Apple (AAPL) Cut to Neutral at UBS.Dynavax (DVAX) ...
Read Full Story »